in fatigue of the musclesresultin fatigue of the muscles
to increases in cellular swellingleadsto increases in cellular swelling
to dyspnoea and compensatory hyperventilation , which could be misinterpreted as a sign of asthma available treatment failuremay leadto dyspnoea and compensatory hyperventilation , which could be misinterpreted as a sign of asthma available treatment failure
in an increase in Hc oxygen - affinity for both Echinogammarus speciesresultedin an increase in Hc oxygen - affinity for both Echinogammarus species
in local brain tissueresultingin local brain tissue
to ketosisleadingto ketosis
to dyspnoea and compensatory hyperventilation , which could be misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatmentmay leadto dyspnoea and compensatory hyperventilation , which could be misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatment
to dyspnoea and compensatory hyperventilation , which could be misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatmenthow may leadto dyspnoea and compensatory hyperventilation , which could be misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatment
to dyspnoea and compensatory from hyperventilation , which could be misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatmentmay leadto dyspnoea and compensatory from hyperventilation , which could be misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatment
to dyspnoea and compensatory hyperventilation , which could be misinterpreted as a sign of asthma available treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatmentmay leadto dyspnoea and compensatory hyperventilation , which could be misinterpreted as a sign of asthma available treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatment
to dyspnoea available and compensatory hyperventilation , which could be available misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatmentmay leadto dyspnoea available and compensatory hyperventilation , which could be available misinterpreted as a sign of asthma treatment failure and lead to inappropriate intensification of short - acting beta - agonist treatment